November 4, 2025 — Leads & Copy —
Travere Therapeutics, Inc. (NASDAQ: TVTX) will participate in several upcoming investor conferences. Management will present at Guggenheim’s 2nd Annual Healthcare Innovation Conference on November 11, TD Cowen Immunology & Inflammation Summit on November 13, and Jefferies Global Healthcare Conference on November 18. They will also attend the Stifel 2025 Healthcare Conference on November 12, the 8th Annual Evercore Healthcare Conference on December 2, and the Piper Sandler 37th Annual Healthcare Conference on December 3.
Live webcasts will be available on the Investor page of Travere’s website, with replays available for 30 days.
Travere Therapeutics is a biopharmaceutical company focused on rare diseases, working with the rare disease community to identify, develop, and deliver life-changing therapies. For more information, visit travere.com.
Source: Travere Therapeutics
